GlassScriptPhysician profile
Thomas J Buell
NPI 1811338627
$13,455.65
in general payments reported to CMS, 2019-2025
13 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.77 · 2022: $10K · 2023: $1,179 · 2024: $984 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,993 · Travel and Lodging: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,993.30 |
| Travel and Lodging | $280.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $9,627.80 | 2022-2023 | Xlif, Pulse, Attrax |
| Globus Medical, INC. | $1,239.35 | 2022-2025 | Excelsius Gps, Modulus, Alif |
| Medtronic, INC. | $636.55 | 2022-2024 | Mazor X System |
| Stryker Corporation | $524.78 | 2022 | |
| Cerapedics INC. | $344.92 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $305.00 | 2024 | |
| Mml US, INC. | $222.09 | 2023 | Reactiv8 |
| Carlsmed, INC. | $181.94 | 2025 | Aprevo |
| Amgen INC. | $140.36 | 2024 | Evenity |
| Zimvie INC. | $106.88 | 2022 | |
| Depuy Synthes Sales INC. | $89.21 | 2024 | Teligen |
| Medical Device Business Services, INC. | $19.00 | 2022 | |
| Medtronic USA, INC. | $17.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Buell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.